Cited In for PMID: 35420683

Year	Number of Results
2022	1
2023	5
2024	1
2025	2

1

Patient-specific comorbidities as prognostic variables for survival in myelofibrosis.

Sochacki AL, Bejan CA, Zhao S, Patel A, Kishtagari A, Spaulding TP, Silver AJ, Stockton SS, Pugh K, Dorand RD, Bhatta M, Strayer N, Zhang S, Snider CA, Stricker T, Nazha A, Bick AG, Xu Y, Savona MR. Sochacki AL, et al. Blood Adv. 2023 Mar 14;7(5):756-767. doi: 10.1182/bloodadvances.2021006318. Blood Adv. 2023. PMID: 35420683 Free PMC article.

2

AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib.

Duminuco A, Mosquera-Orgueira A, Nardo A, Di Raimondo F, Palumbo GA. Duminuco A, et al. Cancer Rep (Hoboken). 2023 Oct;6(10):e1881. doi: 10.1002/cnr2.1881. Epub 2023 Aug 8. Cancer Rep (Hoboken). 2023. PMID: 37553891 Free PMC article.

3

Myelofibrosis.

Passamonti F, Mora B. Passamonti F, et al. Blood. 2023 Apr 20;141(16):1954-1970. doi: 10.1182/blood.2022017423. Blood. 2023. PMID: 36416738 Free PMC article. Review.

4

Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis: a multi-biobank case-control study.

Brogan J, Kishtagari A, Corty RW, Pershad Y, Vlasschaert C, Sharber B, Heimlich JB, Luo L, Ferrell PB, Savona MR, Xu Y, Bick AG. Brogan J, et al. EClinicalMedicine. 2025 Jun 4;84:103283. doi: 10.1016/j.eclinm.2025.103283. eCollection 2025 Jun. EClinicalMedicine. 2025. PMID: 40524801 Free PMC article.

5

Prognostic and Predictive Models in Myelofibrosis.

Mora B, Bucelli C, Cattaneo D, Bellani V, Versino F, Barbullushi K, Fracchiolla N, Iurlo A, Passamonti F. Mora B, et al. Curr Hematol Malig Rep. 2024 Oct;19(5):223-235. doi: 10.1007/s11899-024-00739-6. Epub 2024 Aug 24. Curr Hematol Malig Rep. 2024. PMID: 39179882 Free PMC article. Review.

6

Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis.

Liu T, Fillbrunn M, Zhang S, Chen J, Li W, Platt J, Niehoff N, Sajeev G, Signorovitch J. Liu T, et al. Ann Hematol. 2025 Mar;104(3):1605-1616. doi: 10.1007/s00277-025-06279-0. Epub 2025 Mar 12. Ann Hematol. 2025. PMID: 40069437 Free PMC article.

7

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms.

Mora B, Passamonti F. Mora B, et al. Curr Hematol Malig Rep. 2022 Oct;17(5):127-139. doi: 10.1007/s11899-022-00672-6. Epub 2022 Sep 1. Curr Hematol Malig Rep. 2022. PMID: 36048275 Free PMC article. Review.

8

Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension.

Mulas O, Mola B, Costa A, Pittau F, Mantovani D, Dessì S, Fronteddu A, La Nasa G, Caocci G. Mulas O, et al. Ann Hematol. 2023 Oct;102(10):2717-2723. doi: 10.1007/s00277-023-05417-w. Epub 2023 Aug 21. Ann Hematol. 2023. PMID: 37603060 Free PMC article.

9

Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.

Koster KL, Messerich NM, Volken T, Cogliatti S, Lehmann T, Graf L, Holbro A, Benz R, Demmer I, Jochum W, Rao TN, Silzle T. Koster KL, et al. Cancers (Basel). 2023 Sep 24;15(19):4698. doi: 10.3390/cancers15194698. Cancers (Basel). 2023. PMID: 37835392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 35420683

9 results

Results by year